Quick Answer
Sagimet Biosciences Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $2.00 million for the year ending 2023.
- This data is from Sagimet Biosciences Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2025.
- XBRL data for this metric is available from 2023 to 2023 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: